Abstract: Muscle hyperalgesia and referred pain plays an important role in chronic musculoskeletal pain. New knowledge on the involved basic mechanisms and better methods to assess muscle pain in the clinic are needed to revise and optimize the treatment regimes. Increased muscle sensitivity is manifested as (1) pain evoked by a normally non-nociceptive stimulus (allodynia), (2) increased pain intensity evoked by nociceptive stimuli (hyperalgesia), or (3) increased referred pain areas with associated somatosensory changes. Quantitative sensory testing provides the possibility to evaluate these manifestations in a standardized way in patients suffering from musculoskeletal pain or in healthy volunteers. Some manifestations of sensitisation, such as expanded referred muscle pain areas in chronic musculoskeletal pain patients, can be explained from animal experiments showing extrasegmental spread of sensitisation. An important part of the pain manifestations (eg, tenderness and referred pain) related to chronic musculoskeletal disorders may be due to peripheral and central sensitization, which play a role in the transition from acute to chronic pain. In recent years, it has become evident that muscle pain can interfere with motor control strategies and different patters of interaction are seen during rest, static contractions, and dynamic conditions.
M usculoskeletal pain is a major clinical problem and often insufficiently treated. 1, 2 The neurobiologic mechanisms involved in muscle pain are often difficult to resolve from clinical studies owing to high variability between patients, which may be caused by different pain intensities and duration of their pain condition. Human experimental pain models applied to healthy volunteers are a potential strategy to investigate aspects of the mechanisms involved in muscle pain. Experimental muscle pain research involves 2 separate topics: (1) standardized activation of the nociceptive system and (2) quantitative assessment of the evoked sensory and motor responses. One important advantage with experimental muscle pain studies is that the cause-effect relationship is known. In this situation, healthy volunteers transiently become patients with a well-defined muscle pain where the sensory manifestations and sensory-motor interaction can be assessed. Moreover, experimental techniques may be used in clinical studies to quantify the sensitivity of the nociceptive system in pain patients and in pharmacologic studies.
CHARACTERISTICS OF MUSCLE PAIN
Sensory manifestations of muscle pain are seen as a cramplike, diffuse-aching pain in the muscle, pain referred to distant somatic structures, and modifications in the superficial and deep sensitivity in the painful areas. These manifestations are different from cutaneous pain, which normally is superficial and localized around the injury with a burning and sharp quality. The sensation of acute muscle pain is the result of activation of group III and group IV muscle receptors (nociceptors) responding to strong (noxious) mechanical or chemical stimulation. 3 The nociceptors can be sensitized by release of substances from the nerve endings. This may eventually lead to hyperalgesia and central sensitization of dorsal horn neurones manifested as prolonged neuronal discharges, increased responses to defined noxious stimuli, pain response to non-noxious stimuli, and expansion of the receptive field. 3 In humans, limited information is available on the peripheral neuronal correlate of muscle nociceptor activation, and only few microneurographic studies have been published; the main reasons being difficulties in recording and direct activation of the muscle nociceptors. Other quantitative techniques are therefore needed, and quantitative sensory testing may help to assess muscle pain, muscle hyperalgesia, and referred pain.
QUANTITATIVE ASSESSMENT OF MUSCLE PAIN
The assessment methods of muscle pain are based on psychophysical, electrophysiologic, and imaging techniques. Only psychophysical methods will be described here. Psychophysical determinations can be divided into response-dependent and stimulus-dependent methods. The response-dependent methods are constructed by a series of fixed stimulus intensities and a score to each stimulus. The score can be a visual analog scale (VAS), verbal descriptor scale, magnitude estimation, or crossmodality match. VAS, verbal descriptor scales, McGill Pain Questionnaire, and similar scales and questionnaires may be very helpful for the assessment of perceived intensity and quality. 4 One important advantages of the VAS compared with ordinal scales (eg, numerical scales 0 to 10) is that the VAS have ratio scale properties, 5 that is, for 2 different stimuli intensities, where one of them is perceived as twice the amount of the other, the high VAS score should be twice the low VAS score.
The stimulus-dependent methods are based on adjustment of the stimulus intensity until a predefined response, typically a threshold (eg, detection, pain, or tolerance) is reached. Therefore the uses of scales are avoided. In general, 2 methods to adjust the stimulus intensity exist. In the ''Methods of Limits,'' the stimulus intensity is gradually increased until the threshold is reached, and then decreased again until the stimulus intensity is just below the threshold. The threshold is defined as the mean of the 2 limits. Ascending and descending trials can be repeated to improve reliability. In the ''Method of Constant Stimuli,'' the stimulus intensity is incremented in fixed steps and presented for the patient several times in contrast to the gradual increase as in the Methods of Limits. The threshold is defined as the stimulus intensity that is just above the threshold in 50% of the stimuli.
Stimulus-response functions are more informative than a threshold determination as suprathreshold response characteristics can be derived from the data. For example, the differentiation between low and high intensity stimuli is clearly evaluated by stimulus-response functions. Nevertheless, the stimulus-response function might often be established with stimuli intensities around the pain threshold and therefore both assessment methods are needed. Assessments of the sensory aspects involve both the evaluations of the muscle pain (local pain) and of the somatic structures related to the referred pain area, that is, the ongoing pain intensity and the sensitivity must be described for both areas.
Verbal assessments of the experienced muscle pain intensity and other subjective characteristics of the muscle pain are obviously needed in any clinical and experimental muscle pain studies. The pain intensity is usually scored in a continuous mode on an electronic VAS to characterize the time profile of experimental muscle pain. Experimental muscle pain studies have found that the most frequently used word descriptors to characterize muscle pain are ''drilling,'' ''aching,'' ''boring,'' and ''taut.'' The intensity of muscle pain is easily measured using VAS. However, this is only 1-dimensional aspect of the experienced pain, and additional VAS could be applied to monitor, for example, unpleasantness and soreness.
EXPERIMENTAL MUSCLE PAIN
A number of procedures can induce muscle pain, and they can be divided into endogenous and exogenous techniques. 6 The endogenous techniques are methods that induce muscle pain by natural stimuli, for example, by ischemia or by exercise. The exogenous techniques are external interventions, for example, electrical stimulation of muscle afferents or injection of pain-producing substances. In general, the endogenous experimental techniques induce a widespread deep pain in muscles and other somatic structures, which may be used in studies that require a tissue-unspecific deep pain assessment.
Ischemia
Lewis 7 proposed induction of muscle pain by ischemia. A tourniquet is applied, and after a period of voluntary muscle contractions, a very unpleasant tonic pain sensation develops. The level of force, the number of contractions, and the duration are important determinants for the evoked pain. The involved mechanisms of deep pain after ischemic contractions are not fully understood. Accumulation of various substances (ie, potassium, adenosine, lactate) has been suggested to excite muscle nociceptors or sensitize nociceptors to respond to muscle contractions that are normally nonpainful. 8 This method induces a widespread pain in the entire occluded limb (skin, periosteum, muscle, etc).
Exercise
Exercise-induced muscle pain by concentric muscle work is normally short-lasting and a result of impaired blood flow during work. It may, therefore, resemble the condition of ischemic muscle pain. As an example, muscle pain was induced during cycle ergometry of various loads. 9 Eccentric muscle work may cause delayed onset of muscle soreness with peak soreness after 24 to 48 hours. Delayed onset muscle soreness has been widely used to explore pathophysiologic components of the musculoskeletal system. A model of deep tissue hyperalgesia in wrist extensors with characteristics similar to tennis elbow pain has recently been described. 10 The mechanism underlying delayed onset muscle soreness is probably related to ultrastructural damage, resulting in the release of painrelated substances. 11 This may produce an inflammatory reaction, as an anti-inflammatory drug (nonsteroidal antiinflammatory drugs) seems to have an effect on this type of jaw muscle soreness. 12 Howell et al 13 were, however, unable to demonstrate an nonsteroidal anti-inflammatory drugs effect on delayed soreness in limb muscles. Another feature of delayed onset of muscle soreness is the fact that there is no pain at rest, but pain is evoked by muscle function and during palpation. This is in contrast to spontaneous pain induced by the exogenous experimental techniques.
Electrical
In human studies, intramuscular (IM) electrical stimulation ( Fig. 1A) can be used to assess the sensitivity of muscles, to study basic aspects of deep pain, and to investigate electrophysiologic properties of muscle afferents by microneurography. IM electrical stimulation is a tissue-specific (although receptor unspecific) and reliable model to study sensory manifestations of muscle pain such as referred pain and temporal summation, but is confounded by concurrent activated muscle twitches. Electrical stimulation offers a unique possibility to compare both muscle and cutaneous tissues with the same stimulus modality; for example, a systemic given anesthetic drug (remifentanil) caused a higher increase in the pain threshold to IM electrical stimulation compared with the relative increase in pain thresholds induced by cutaneous stimulation.
14 This indicates that remifentanil inhibits muscle pain more effectively than cutaneous pain. Electrical stimulation has also been extensively used to explore mechanisms of referred pain.
Mechanical
Mechanical painful stimulation can be achieved with pressure algometers (Fig. 1B) . The most widely used technique is manual pressure algometry. It is important to recognize that pressure stimulates both the skin and muscle. Anesthetizing the skin can, however, reduce the skin pain contribution during pressure stimulation. 15 Pressure algometry is actually recommended as one of the diagnostic procedures for evaluation of patients with tension-type headache, but so far not for examination of other musculoskeletal pain conditions. Methodologic concerns like short-term and long-term reproducibility, influence of pressure rates and muscle contraction levels, and examiner expectancy have all been addressed carefully (for references, see Graven-Nielsen et al 15 ). An alternative to pressure algometry, and to the inherent variability related to manual application, is computer-controlled pressure algometry where the rate and peak pressure can be predefined and automatically controlled (Fig. 2) . This method allows estimation of the stimulus-response function between pressure and pain intensities. 15 The facilitated pain response to sequential stimuli of equal strength is defined as temporal summation. The facilitated degree of temporal summation indicates an enhanced central integrative mechanism (central sensitization). Repeated tapping on muscle by a pressure probe has recently been used to assess the efficacy of temporal summation. 16 Pressure algometry assesses a relatively small volume of tissue. Instead a larger volume can be assessed by computer-controlled cuff-algometry technique. In short, the pain intensity related to inflation of a tourniquet applied around an extremity can be used to establish stimulus-response FIGURE 1. The muscle pain sensitivity can be assessed by electrical, chemical, and mechanical stimulation of muscle nociceptors. A, Needle electrodes inserted into the tibialis anterior muscle. The tip of the electrodes is uninsulated and the muscle nociceptors can be excited by constant current stimulation at stepwise increasing intensities until the pain threshold is reached. Various algesic substances can also be infused into the muscle and thereby excite the muscle nociceptors. In this situation, the pain intensity to a specific infusion paradigm is scored on a VAS where the end points indicate no pain and maximal pain. B, With the handheld pressure algometer, the pressure intensity is manually increased until the patient presses a button when the pressure becomes painful. The actual pressure intensity where the stimulation was stopped defines the pressure pain threshold. curves assessing the deep tissue sensitivity. After IM injections of anesthetics (lidocaine), the stimulus-response curve between the tourniquet pressure and pain intensity was right-shifted, indicating the ability to assess the sensitivity of muscles. 17 A left-shifted stimulus-response curve between the tourniquet pressure and pain intensity illustrates deep tissue hyperalgesia.
Chemical
IM injections of pain-producing substances (ie, glutamate, capsaicin, hypertonic saline) have been used to induce human muscle pain (see Graven-Nielsen et al 18 ). The experimental method that has been used extensively is IM injection of hypertonic saline, as the quality of the induced pain is comparable with acute clinical muscle pain with localized and referred pain (Fig. 3) . The work of Kellgren 19 in the late 1930s initiated the method of salineinduced muscle pain, and the safety of the technique is illustrated by no reports of side effects after more than 1000 IM infusions. Recent animal studies have shown that the method does not cause muscle toxicity and therefore it is adequate for human experimentation. A major advantage of the hypertonic saline model is that a detailed description of sensory and motor effects can be obtained as the pain lasts for minutes (Fig. 3) . Furthermore, the model is reliable for studying referred pain from musculoskeletal structures owing to the longer lasting pain. In most of the earlier studies, manual bolus infusions of hypertonic saline have been used. However, standardization of the infusion of small volumes is easier to accomplish by computer-controlled infusion pumps. A systematic evaluation of the infusion parameters (infusion concentration, volume, rate, and tissue) has been studied on pain intensity, quality, and also on local and referred pain patterns. 20 The sensitization of muscle nociceptors is the bestestablished peripheral mechanism for the subjective tenderness and pain during movement of a damaged muscle. The sensitized nociceptors not only have a lowered mechanical excitation threshold, but also exhibit larger responses to noxious stimuli. If the muscle lesion is extensive, high amounts of endogenous pain-producing agents will be released, which could lead to direct excitation of nociceptors resulting in spontaneous pain. In humans, this has been reported as decreased pressure pain thresholds after IM injections of capsaicin. 21 Intraarterial injections of serotonin, bradykinin, and prostaglandin have been found effective in sensitizing animal nociceptors. 3 In humans, a decrease in the pressure pain threshold after combined IM injections of serotonin and bradykinin was found. 22 IM injections of glutamate produce pain and muscle hyperalgesia to pressure stimuli in humans. 23 Interestingly, injections of glutamate in women induced significantly more muscle pain than similar injections in men. 24 This might be explained by a greater glutamate-evoked afferent fiber activity in female compared with male rats. 24 This sex difference is particularly important in relation to the high dominance of women with musculoskeletal pain syndromes.
REFERRED PAIN
Pain perceived at a site adjacent to or at a distance from the site of origin is defined as referred pain (Fig. 3) . To distinguish between ''referred pain'' and ''spread of pain,'' referred pain is typically restricted to areas outside the local pain area. Referred pain has been known and described for more than a century and has been used extensively as a diagnostic tool in the clinic. Originally the term referred tenderness and pain was used. Mainly musculoskeletal and visceral pain conditions are accompanied by local or referred pain.
Kellgren 19 was one of the pioneers to study experimentally the characteristics of muscle pain and the actual locations of referred pain to selective stimulation of specific muscle groups. Several theories regarding the appearance of referred pain have been suggested, but no firm neurophysiologic-based explanations for referred pain exist. It has been shown that wide dynamic range neurones and nociceptive-specific neurones in the spinal cord and in the brain stem receive convergent afferent input from the skin, muscles, joints, and viscera. This may cause misinterpretation of the afferent information coming from muscle afferents when reaching higher levels in the central nervous system, and hence be one reason for the diffused and referred characteristics.
Referred pain is probably a combination of central processing and peripheral input, as it is possible to induce referred pain to limbs with complete sensory loss owing to an anesthetic block. However, the involvement of peripheral input from the referred pain area is not clear as anesthetizing this area shows inhibitory or no effects on the referred pain intensity. Central sensitization may be involved in the mechanism of referred pain. A complex network of extensive collateral synaptic connections for each muscle afferent fiber onto multiple dorsal horn neurones is assumed. 3 Under normal conditions, afferent fibers have fully functional synaptic connections with dorsal horn neurones and latent synaptic connections to other neurones within the same region of the spinal cord. After ongoing strong noxious input, latent synaptic connections become operational thereby allowing for convergence of input from more than one source. Animal studies show a development of new or expansion of existing receptive fields by a noxious muscle stimulus. Recordings from a dorsal horn neurone with a receptive field located in the biceps femoris muscle show new receptive fields in the tibialis anterior muscle and at the foot after noxious stimulation of the tibialis anterior muscle. 25 In the context of referred pain, the unmasking of new receptive fields owing to central sensitization could mediate referred pain. The area of the referred pain is correlated with the intensity of the muscle pain and the appearance of referred pain is delayed (20 to 40 s) compared with the local muscle pain, indicating that a time-dependent process, like the unmasking of new synaptic connections (see above), is involved in the neural mediation of referred pain.
Substantial clinical knowledge exists on the patterns of referred muscle pain from various skeletal muscles and after activation of trigger points in myofascial pain patients. Referral of muscle pain is typically described as a sensation from deep structures in contrast to visceral referred pain that is both superficially and deeply located. The pattern and size of referral seem to be changed in other chronic musculoskeletal pain conditions; for example, fibromyalgia patients experience stronger pain and larger referred areas after exogenous muscle pain (hypertonic saline) compared with matched controls. 26 Interestingly, these manifestations were present in lower limb muscles where the patients typically do not experience ongoing pain. Normally pain from the tibialis anterior is projected distally to the ankle and only rarely proximally (Fig. 3) . In fibromyalgia patients, substantial proximal spread of the experimentally induced referred pain areas was found. Enlarged referred pain areas in pain patients suggest that the efficacy of central processing is increased (central sensitization). Moreover, the expanded referred pain areas in fibromyalgia patients were partly inhibited by ketamine (an N-methyl-D-aspartate receptor antagonist) targeting central sensitization. 27 Extended referred pain areas from the tibialis anterior muscle, indicating central sensitization, have also been shown in patients suffering from other chronic musculoskeletal pain conditions. 28 
SENSORY-MOTOR INTERACTION IN MUSCLE PAIN
It is well accepted from daily life activities that muscle pain interacts with the movement performance. This section illustrates how muscle pain affects the muscle control in different ways depending on the specific motor task (Fig. 4) .
Resting Muscle Activity and Muscle Pain
Increased resting muscle activity after salineinduced muscle pain is found compared with baseline recordings, but not compared with a sham pain condition where patients recalled a painful condition without having the actual pain stimulation. 29 This indicates that hyperactivity is not present owing to the muscle pain per se. In another study, a transient increase in the resting electromyographic (EMG) activity during infusion of hypertonic saline was recorded in contrast with infusion of isotonic saline. 30 Importantly, on-going muscle pain did not produce sustained increased EMG activity. Moreover, experimental muscle pain does not cause any changes in resting EMG activity between repeated, maximal voluntary contractions (MVC). 31 In contrast to the experimental studies, both increased and unchanged resting EMG activity have been reported in musculoskeletal pain patients.
Static Muscle Activity and Muscle Pain
The maximal voluntary contraction during salineinduced muscle pain is significantly lower than in the control condition. 32 Attenuation of MVC force during experimental muscle pain was not associated with the changes in contractile properties of muscle fibers, but to a pure central effect; that is, a motor control modulation. A clinical demonstration of the observed decrease in muscle strength during voluntary isometric contractions of a painful muscle has also been made in musculoskeletal pain patients. In fibromyalgia patients, the reduction in strength is suggested to be due to a deficient central activation of motor units because supramaximal stimulation of the ulnar nerve shows no difference in the strength of the adductor pollicis muscle between patients and a control group. 33 The modulating effect of muscle pain on motor control is highlighted by a correlation between pain intensity and EMG changes 34 or motor unit firing inhibition 35 in static contractions. During a static contraction (ie, 80% of the MVC before pain), experimental muscle pain causes a 4. Summary of findings on the interaction between muscle pain and motor control. In resting conditions, there is no effect of muscle pain on the muscle activity of the painful muscle. In static contractions, the muscle activity is decreased both in the painful muscle and in other synergistic muscles. The synergistic muscles are not painful, but involved in the force generation together with the painful muscle. In dynamic contractions, the general finding is decreased agonistic muscle activity and in some situation also increased antagonistic muscle activity independently of which muscle is painful.
significant reduction in endurance time. 36 The different findings between submaximal and maximal contractions may be explained by changes in the descending neural drive to motorneurones. The descending neural drive cannot be voluntarily increased during MVC, and an inhibitory mechanism controlling the motorneurones might therefore explain the decreases in MVC. When submaximal contractions are performed, the voluntary neural drive may be increased and thus compensate for potential inhibitory mechanisms. An interesting observation is that the muscle pain during static contractions not only decreases the muscle activity of the painful muscle, but also attenuates synergistic muscles. 36 To produce the required force, the generalized inhibition calls for a changed muscle coordination and eventual overload of otherwise nonpainful muscles. In accordance with experimental findings, a decreased endurance time is reported in musculoskeletal pain patients performing a submaximal contraction compared with age-matched and sex-matched control patients. If submaximal contractions during muscle pain are obtained by increased voluntary neural drive, the decreased endurance time may alternatively be due to a more pronounced central fatigue. 37 In clinical studies, various physiologic factors within the muscle (eg, microcirculation) could influence endurance time, but this is not likely to occur in healthy volunteers exposed to acute muscle pain.
Dynamic Muscle Activity and Muscle Pain
The lumbar muscle EMG activity during a flexionextension exercise is higher in low back pain patients in full extension than in control patients where it is normally silent. 38 This indicates that the pain modulation of muscle activity is dependent on the specific muscle function (agonist/antagonist phases). This has been found in several previous clinical studies (for review, see Lund et al 39 ) . The lumbar muscle EMG activity in low back pain patients and during saline-induced lumbar muscle pain is (1) increased in phases where the EMG activity is normally silent, and (2) not affected or decreased in the phases with strong EMG activity in control patients. 34 During dynamic contractions, muscle pain causes decreased EMG in the agonistic phase 40 and increased EMG in the antagonistic phase 31 of the muscle activity in painful muscles. Decreased activity in both the agonistic and antagonistic muscles during muscle pain has been found without impairing the movement amplitude or acceleration significantly. 41 Especially, the initial (100 ms) agonistic EMG burst activity was decreased, illustrating that the motor strategy was affected by muscle pain. This might be highly important in occupational settings where such a change may need compensatory actions from other muscles to fulfill the required movement and thereby possibly contribute to the development of musculoskeletal pain problems. Increased trapezius activity during contractions has been found during biceps muscle pain that might illustrate a compensatory action. 41 Reduced movement amplitudes have been reported in many experimental and clinical musculoskeletal pain conditions such as low back pain. The increased EMG activity of the muscle (antagonistic phase) opposite to the painful muscle and the decreased EMG activity of the painful muscle (agonistic phase) are probably a functional adaptation of muscle coordination to limit movements. This adaptation may protect the painful muscle by reducing the muscle activity and contraction force. Similar functional protection may account for painful muscles showing increased muscle activity in the antagonistic phase. In this case, a reduction in the muscle lengthening (a result of decreased movement amplitude by increased activity in the antagonistic phase) may protect the painful muscle.
Experimental models of muscle pain have also been used in occupational settings (low load, repetitive work) where saline-induced neck muscle pain was found to cause changes in motor strategies, for example, a decreased working rhythm and a muscle coordination change which may be interpreted as protective. 42 Intensive studies of the relationship between work-related muscle pain and muscle activity have been carried out in an attempt to find a valid predictor for the development of neck-shoulder pain. A decreased frequency of unconscious gaps in the low-level EMG activity was found to predict the patients who developed neck-shoulder pain. 43 A higher EMG level during low load repetitive work was found among the group of workers who developed neckshoulder complaints, highlighting that the level of activity may have some prognostic relevance for the development of chronic neck-shoulder pain. 44 
Neurophysiologic Mechanisms
Muscle hyperactivity initiated by a vicious cycle due to ischemia was one of the first theories trying to explain the cause of muscle pain. 45 Hyperactivity was also proposed in the reflex-spasm and stress-causality models, which are based on either a few experimental observations or literature reviews and thus not systematically investigated. 46 In addition, a physiologic model based on animal data suggests muscle hyperactivity owing to facilitation of the muscle-spindle system by muscle pain. 47 The evidence for human muscle hyperactivity is, however, not convincing (Fig. 4) .
Lund et al 39 suggested the pain-adaptation model to explain the link between activity in nociceptive afferents, a central pattern generator, the motor function, and coordination of muscles. This pain-adaptation model predicts increased muscle activity in antagonistic phases and decreased muscle activity in agonistic phases during muscle pain. Such a coordination may produce a decrease in movement amplitude and velocity. The pain-adaptation model includes inhibition and excitation of motorneurones according to the functional phases (agonist or antagonist) of the painful muscle. Findings indicate that the coordination change owing to muscle pain is not voluntary, but caused by a reflex mechanism because (1) muscle pain affects the muscle activity in heteronymous muscles, and (2) muscle pain differentially modulates the muscle activity during one movement-cycle depending on the specific muscle function.
CONCLUSIONS
A significant part of the manifestations of muscle and myofascial pain (eg, tenderness and referred pain) in chronic musculoskeletal disorders may be the results of peripheral and central sensitization. Reliable methods for quantitative induction and assessment of muscle sensitization, referred pain, and muscle sensitivity are available. From a mechanistic point of view, sensory assessment procedures can provide complementary clinical information and give qualified clues to revise and optimize treatment regimes.
The interactions between muscle pain and motor control depend on the specific motor task. Muscle pain causes no increase in EMG activity at rest and reduces MVC and endurance time during submaximal contractions. Moreover, muscle pain causes a change in coordination during dynamic exercises. This is in line with the pain-adaptation model predicting a decrease in movement amplitude and velocity when muscle pain is present. The functional adaptation to muscle pain may also involve increased muscle activity, reflecting changed muscle coordination and strategy.
